Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+2.73%)
As of: Oct 2, 2026 · 9:56 AM EDT

Rani Therapeutics Holdings (RANI) Interest Expenses (2020 - 2026)

Updated

Rani Therapeutics Holdings' Interest Expenses was $8,000 in Q2 2026, down 99.1% from $877,000 a year earlier and down 90.9% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Interest Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Rani Therapeutics Holdings' Interest Expenses was $1.17 million through Jun 30, 2026, down 72.7% year-over-year; for FY2025, it came in at $2.89 million, down 42.6% from FY2024.

  • Interest Expenses shows a five-year compound annual growth rate of 87.7% (FY2020 to FY2025).
  • In earlier years, Interest Expenses was $5.03 million in FY2024 (-1.0%), $5.09 million in FY2023 (+374.8%), $1.07 million in FY2022 (+129.8%) and $466,000 in FY2021 (+275.8%).
  • The Q2 2026 figure marks the lowest quarterly Interest Expenses since Q4 2021.
  • Compared with a year earlier, Interest Expenses has declined for seven straight quarters, with an average decline of 46.8% over the last eight quarters.
  • The best year-over-year quarter for Interest Expenses over five years was Q3 2023 (growth of 273.9%); the worst was Q2 2026 (a decline of 99.1%).
  • Per Business Quant data, RANI's Interest Expenses in the three quarters before Q2 2026 was $88,000 (Q1 2026), $347,000 (Q4 2025) and $725,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - 8,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8,000.00
Mar 31, 2026 88,000.00
Dec 31, 2025 347,000.00
Sep 30, 2025 725,000.00
Jun 30, 2025 877,000.00
Mar 31, 2025 943,000.00
Dec 31, 2024 1.12 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 1.28 Mn
Mar 31, 2024 1.29 Mn
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.27 Mn
Mar 31, 2023 1.21 Mn
Dec 31, 2022 719,000.00
Sep 30, 2022 352,000.00
Dec 31, 2021 -1,000.00
Sep 30, 2021 110,000.00
Jun 30, 2021 169,000.00
Mar 31, 2021 188,000.00
API Access

Rani Therapeutics Holdings Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=RANI&period=max&api_key=YOUR_API_KEY